Zhejiang Hisun Biomaterials Co.Ltd. (SHA:688203)
China · Delayed Price · Currency is CNY 13.01
-0.02 (-0.15%)
Apr 28, 2026, 4:00 PM EDT
SHA:688203 Revenue
Zhejiang Hisun Biomaterials Co.Ltd. had revenue of 267.56M CNY in the quarter ending March 31, 2026, with 30.28% growth. This brings the company's revenue in the last twelve months to 913.88M, up 6.44% year-over-year. In the year 2025, Zhejiang Hisun Biomaterials Co.Ltd. had annual revenue of 851.69M with 0.77% growth.
Revenue (ttm)
913.88M
Revenue Growth
+6.44%
P/S Ratio
2.86
Revenue / Employee
2.05M
Employees
446
Market Cap
2.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 851.69M | 6.50M | 0.77% |
| Dec 31, 2024 | 845.19M | 91.87M | 12.20% |
| Dec 31, 2023 | 753.32M | 147.88M | 24.43% |
| Dec 31, 2022 | 605.43M | 20.43M | 3.49% |
| Dec 31, 2021 | 585.01M | 322.34M | 122.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Aoyang Health Industry Co.ltd. | 1.81B |
| Daqing Huake Company | 1.78B |
| Gpro Titanium Industry | 1.75B |
| Hunan Hengguang Technology | 1.49B |
| Zhe Jiang Dayang Biotech Group | 985.47M |
| Yangzhou Chenhua New Material | 923.15M |
| Yangfan New Materials (Zhejiang) | 912.69M |
| Zhejiang Benli Technology | 638.51M |